Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Jay R. Luly, Ph.D. reported a 7.70% stake in Enanta Pharmaceuticals, Inc. (Schedule 13D/A)

Event Feb 12, 2025 · Filed Feb 14, 2025

Jay R. Luly, Ph.D. reported a 7.70% stake in Enanta Pharmaceuticals, Inc., 1,703,616 shares, with active intent on Feb 12, 2025. Filed Feb 14, 2025 (Schedule 13D/A).

Stake
7.70%
Shares
1,703,616
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Jay R. Luly, Ph.D.7.70%1,703,616

Source

View original at SEC

Related